当前位置:首页 - 行情中心 - 春立医疗(688236) - 财务分析 - 现金流量表

春立医疗

(688236)

  

流通市值:66.92亿  总市值:88.99亿
流通股本:2.88亿   总股本:3.84亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金565,945,760.08154,928,044.7898,017,108.57704,325,961.65
  收到的税费返还2,729,410.74-12,079,193.043,949,002.56
  收到其他与经营活动有关的现金11,886,857.735,079,610.4344,382,434.7531,276,669.26
  经营活动现金流入小计580,562,028.55160,007,655.13954,478,736.36739,551,633.47
  购买商品、接受劳务支付的现金200,241,512.11118,196,154.09357,543,776.96254,181,935.07
  支付给职工以及为职工支付的现金110,009,221.4556,582,807.71246,954,981.06195,375,092.18
  支付的各项税费14,727,332.1510,570,701.9675,353,479.9567,437,773.37
  支付其他与经营活动有关的现金114,097,579.7450,001,576.97276,526,049.32239,836,246.6
  经营活动现金流出小计439,075,645.45235,351,240.73956,378,287.29756,831,047.22
  经营活动产生的现金流量净额141,486,383.1-75,343,585.6-1,899,550.93-17,279,413.75
二、投资活动产生的现金流量:
  收回投资收到的现金744,000,000744,000,0002,330,000,0001,570,000,000
  取得投资收益收到的现金6,619,109.046,619,109.0420,636,632.8712,955,317.8
  处置固定资产、无形资产和其他长期资产收回的现金净额23,000-21,00089,090.12
  投资活动现金流入小计750,642,109.04750,619,109.042,350,657,632.871,583,044,407.92
  购建固定资产、无形资产和其他长期资产支付的现金30,116,695.8618,309,973.6949,171,760.2632,216,273.35
  投资支付的现金860,000,000-2,244,000,0001,500,000,000
  取得子公司及其他营业单位支付的现金2,200,000-1,650,000-
  投资活动现金流出小计892,316,695.8618,309,973.692,294,821,760.261,532,216,273.35
  投资活动产生的现金流量净额-141,674,586.82732,309,135.3555,835,872.6150,828,134.57
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金--170,533,715.46138,769,585.99
  支付其他与筹资活动有关的现金8,618,899.6335,877.1412,605,553.295,588,314.32
  筹资活动现金流出小计8,618,899.6335,877.14183,139,268.75144,357,900.31
  筹资活动产生的现金流量净额-8,618,899.63-35,877.14-183,139,268.75-144,357,900.31
四、汇率变动对现金及现金等价物的影响-275,701.1887,041.012,207,522.061,677.48
五、现金及现金等价物净增加额-9,082,804.53657,016,713.62-126,995,425.01-110,807,502.01
  加:期初现金及现金等价物余额1,139,017,650.661,139,017,650.661,266,013,075.671,266,013,075.67
  期末现金及现金等价物余额1,129,934,846.131,796,034,364.281,139,017,650.661,155,205,573.66
补充资料:
  净利润114,481,155.04-124,661,283.5-
  资产减值准备26,911,765.98-33,776,793.41-
  固定资产和投资性房地产折旧13,300,195.1-25,962,979.19-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧13,300,195.1-25,962,979.19-
  无形资产摊销6,376,890.11-10,914,440.37-
  处置固定资产、无形资产和其他长期资产的损失-3,848.03--39,213.61-
  公允价值变动损失-4,296,252.04--9,434,830.14-
  财务费用287,993.88--2,162,582.99-
  投资损失-3,217,026.86--10,980,482.17-
  递延所得税-3,284,665.23-2,900,211.92-
  其中:递延所得税资产减少-4,036,046.42-1,518,832.25-
    递延所得税负债增加751,381.19-1,381,379.67-
  存货的减少-38,635,181.65--136,774,192.51-
  经营性应收项目的减少87,729,121.24-63,203,573.41-
  经营性应付项目的增加-70,916,603.28--108,913,625.87-
  现金的期末余额1,129,934,846.13-1,139,017,650.66-
  减:现金的期初余额1,139,017,650.66-1,266,013,075.67-
  现金及现金等价物的净增加额-9,082,804.53--126,995,425.01-
公告日期2025-08-302025-04-302025-03-292024-10-31
审计意见(境内)标准无保留意见
TOP↑